LULL1 Activators encompass a distinct category of chemical compounds that play a pivotal role in modulating the activity of LULL1 protein through their specific interactions with cellular signaling pathways. These activators are adept at fine-tuning the biological processes that LULL1 is involved in, primarily by influencing the activity of enzymes and receptors that are upstream or downstream in the signaling cascade. For instance, certain small molecule agonists might target G-protein-coupled receptors (GPCRs), leading to a cascade of intracellular events that culminate in the activation of LULL1. These events can include the alteration of cyclic AMP (cAMP) levels, which are often a secondary messenger in signaling pathways that LULL1 participates in. By increasing cAMP, these activators can potentiate the protein's ability to interact with its natural substrates or partners within the cell, thereby enhancing its functional role without directly increasing its expression or altering its transcriptional regulation.
Moreover, LULL1 Activators may also include kinase activators, which function by phosphorylating specific amino acid residues on proteins within the signaling pathways that LULL1 is a part of. This post-translational modification can lead to a conformational change in LULL1 or its associated factors, which in turn can increase the protein's activity. Another class of these activators operates through the modulation of intracellular calcium levels, which are critical for the function of many proteins, including LULL1. By increasing the availability of calcium, these chemicals can enhance LULL1's activity indirectly by activating calcium-dependent signaling proteins that interact with LULL1. Each activator within this class has a unique molecular mechanism, yet they all converge on the common outcome of enhancing the functional activity of LULL1. Through such precise and targeted molecular interactions, LULL1 Activators are able to exert their effects on the protein's activity, engaging it more effectively in its role within cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates PKA, which can phosphorylate LULL1, potentially leading to its enhanced functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing the breakdown of cAMP. This elevation in cAMP levels can enhance PKA activity, which may increase the functional activity of LULL1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), which could phosphorylate LULL1 or associated proteins, leading to its enhanced activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent protein kinases (CaMK), potentially enhancing the activity of LULL1 through direct or indirect phosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels within the cell, which could contribute to the enhanced activity of LULL1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases, potentially altering the phosphorylation state of LULL1 or its interactors, resulting in enhanced LULL1 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule can activate sphingosine-1-phosphate receptors, leading to downstream kinase activation that may enhance the activity of LULL1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins, a family of protein deacetylases, which can modulate the activity of LULL1 either through direct deacetylation or via regulation of its interacting partners. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate various signaling pathways, including the inhibition of NF-κB pathway, potentially altering the functional environment to favor LULL1 activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor, which may lead to a relaxed chromatin structure around the target sites of LULL1, potentially enhancing its activity. | ||||||